Loading

Annals of Community Medicine and Practice

Larvicidal Activity of the Lignan desoxypodophyllotoxin Against Aedes albopictus

Short Communication | Open Access

  • 1. Laboratório de Insetos Vetores, Universidade Severino Sombra, Brazil
  • 2. Mestrado Profissional em Ciências Aplicadas em Saúde, Universidade Severino Sombra, Brazil
  • 3. Mestrado Profissional em Ciências Ambientais, Universidade Severino Sombra, Brazil
  • 4. Laboratório de Entomologia Médica e Forense, Insituto Oswaldo Cruz/FIOCRUZ, Brazil
  • 5. Laboratório Interdisciplinar de Vigilância Entomológica em Díptera e Hemíptera, Instituto Oswaldo Cruz/FIOCRUZ, Brazil
  • 6. Laboratório de Transmissores de Hematozoários e Núcleo Operacional Sentinela de Mosquitos Vetores, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, RJ, Brazil.
  • 7. Serviço de Biotecnologia Vegetal, Divisão de Ciência e Inovação, Fundação Ezequiel Dias, Brazil
+ Show More - Show Less
Corresponding Authors
Dra Marise Maleck, Laboratório de Insetos Vetores, Universidade Severino Sombra, Avenida Expedicionário Oswaldo Almeida Ramos, 280, 27700-000, Vassouras, RJ, Brazil, Tel: 55 24 2471 8351
Abstract

Aedes (Stegomyia) albopictus (Skuse, 1894) (Diptera: Culicidae), the Asian tiger mosquito, is a less efficient vector of dengue compared to Ae. aegypti although, it is able to transmit other arboviruses and thus, should remain a concern for the public health. Dengue is regarded as the most rapidly spread mosquito-borne infectious disease world. Disease prevention is dependent on controlling the mosquito population. Plant-derived natural products have been investigated in the search for new insecticides and larvicides aiming to help in the control of insects and their larvae. Lignans are phenolic compounds mainly distributed in plants even though they are found in other organisms and the insecticidal properties have been reported. This communication describes the evaluation of the activity of desoxypodophyllotoxin (1), isolated from the rhizomes and roots of Podophyllum hexandrum against the mosquito Ae. albopictus. Bioassays were performed on 25 larvae (L3) of Ae. albopictus. The desoxypodophyllotoxin was dissolved in a mixture of acetone: dimethylsulfoxide (DMSO) (1:1) and applied at final concentrations of 1-30 µg/mL. The mortality (100%) of the Ae. albopictus larval was observed in all the concentrations occurred. This study showed the larvicidal activity of the lignan desoxypodophyllotoxin (1) against the larvae of Ae. albopictus, and to some extent, confirms its potential as an application in the control of mosquitoes, the main vectors of arboviruses.

Citation

Maleck M, da Silva Pedra Parreira W, Serdeiro MT, Tavares Vieira RR, Honório NA, et al. (2017) Larvicidal Activity of the Lignan desoxypodophyllotoxin Against Aedes albopictus. Ann Community Med Pract 3(2): 1022.

Keywords

•    Aedes albopictus
•    Desoxypodophyllotoxin
•    Lignan
•    Podophyllum hexandrum
•    Larvicidal activity

INTRODUCTION

Aedes (Stegomyia) albopictus (Skuse, 1894) (Diptera: Culicidae), is a mosquito originally from Asia which is also an invasive species that can also be found in areas of tropical, subtropical and temperate climates [1]. It has been reported that this Asian tiger mosquito is a less efficient vector of dengue compared to Ae. aegypti although, it offers a special concern to the public health implications because it is able to transmit other arboviruses such as chikungunya [2]. It can also transmit heartworm parasites [1] in dogs. Dengue is regarded as the most rapidly spread mosquito-borne infectious disease world. Despite its consequences, there is no effective treatment for patients who rely on supportive care. Moreover, disease prevention is dependent on controlling the mosquito population [3]. The use of conventional insecticides is not safe since some of them are toxic to humans and to non-target organisms and limited success has been achieved with them. In addition, due to repeated applications, the emergence of insecticide resistance in mosquitoes has increased and this causes environmental damage. Furthermore, vector control is costly and has only been partially successful in reducing transmission of the disease. Controlling the mosquito at the larval stage may be an alternative.

Plant-derived natural products have been investigated in the search for new insecticides and larvicides aiming to help in the control of insects and their larvae. It is desirable to find an environmentally safe, biodegradable and target insecticide. Many natural products are highly active against arthropods particularly alkaloids, phenolic compounds and terpenoids [4].

Lignans are phenolic compounds mainly distributed in plants even though they are found in other organisms. Their biological activities were fully reviewed by MacRae and Towers (1984) [5], and include antibacterial, antifungal, antiviral and antioxidant activity. Besides the insecticidal properties of lignans have also been reported [6].

Podophyllum species have well known lignan profiles [7], and podophyllotoxin and its derivatives have received more attention due to their medicinal applications [8]. On the other hand, the spectrum of activities for these compounds is being expanded due to their effect on insects by known lignans [9]. In a recent study, we have reported that the larvicidal activity of podophyllotoxone against the larvae of Ae. aegypti made a possible contribution to the delayed development of its larvae [10].

Our research group is currently investigating the insecticidal and larvicidal potential of plants containing lignans and their isolated compounds and their use against vectors of great concern to the public health. This communication describes the evaluation of the larvicidal activity of desoxypodophyllotoxin (1) (Figure 1), against the mosquito Ae. albopictus. In a previous study [10], we reported on the isolation and identification of this compound from an ethanolic (EtOH) extract from the rhizomes and roots of Podophyllum hexandrum.

MATERIALS AND METHODS

Ae. albopictus eggs were obtained from the Núcleo Operacional Sentinela de Mosquitos Vetores, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro. The bioassays were held in the Laboratório de Insetos Vetores, Universidade Severino Sombra, Rio de Janeiro. The larvae at 3rd stage (L3) were pooled and separated for the bioassays.

Desoxypodophyllotoxin (1) was dissolved in a mixture of acetone: dimethylsulfoxide (DMSO) (1:1) and applied at final concentrations of 1, 10 and 30 µg/mL in a receptacle containing mineral water (25 mL) and a diet of fishmeal (Alcon Guppy) at a dose of 0.3 mg/larva. Twenty-five third-stage (L3) larvae were used per group: test, control (without desoxypodophyllotoxin (1) and without a mixture of acetone: DMSO) and testimony control (with a mixture of acetone: DMSO). The experiments were performed in triplicate, totaling 75 larvae (L3) per group, with three repetitions. The larvae were maintained in a climate-controlled chamber at 28 ± 1 °C and 70 ± 10% relative humidity. The bioassays followed the methodology described by Maleck and collaborators (2017) [10], which were adapted from WHO (2005) [11]. The data were analyzed by means of one-way ANOVA with means separated using the Tukey test with a significance level of 5% [12], and standard deviations were calculated using the averages from the experiments through GraphPad Instat 3.05 [13]. The LC50value was calculated by means of Trimmed Spearman-Karber analysis [14].

RESULTS AND DISCUSSION

In this study, the treatment with desoxypodophyllotoxin (1) showed that the L3-L4 larval development was reduced (1-5 d) at the concentrations of 1 µg/mL, 10 µg/mL, and 30 µg/ mL when compared with both controls which showed delayed development of larvae (1-10 d) (Table 1A).

The larvae (L3) of Ae. albopictus treated with desoxypodophyllotoxin showed L3-L4 viability of 52% (1 µg/ mL), 25% (10 µg/mL) and 28% 30 μg/mL (Table 1B). Both controls presented 100% viability of the L3-adult, however at the same concentrations evaluated (1, 10 and (30 μg/mL)) the larvae did not reach the adult phase as shown (Table 1B).

Regarding mortality, the concentration of 1 µg/mL of compound (1) affected 48% (12 ± 8.7) of the L3 larvae between the 1st to 3rd day. The high mortality rate above 70% for L3 was observed at 10 µg/mL (15.3 ± 11.1) (2-7 d) and 30 µg/mL (18 ± 7) (1-6 d) concentration. The data showed a toxic activity with an LC50 of 1.1 µg/mL. The mortality (100%) of the Ae. albopictus larval (L3+L4) was observed in all the concentrations occurred of the 1st to 7th (Table 1C).

Studies with lignans have shown their effects on the insects. In studies with podophylltotoxin and deoxypodophyllotoxin, both compounds have shown insecticidal activity against larvae of Epilachna sparsa orientalis [15]. According to the authors, deoxypodophyllotoxin was also active against adult females of Culex pipiens molestus, Musca domestica, Blatella germanica and Periplaneta fuliginosa [15].

Cabral and collaborators (2000) [9] evaluated some lignans and neolignans as inhibitors of ecdysis on four instar larvae of Rhodnius prolixus, a major vector of Chagas disease. Podophyllotoxin caused a high moulting inhibition and significant toxicity when applied either orally and topically. Whereas the high percentage of ecdysis inhibition (58%) was observed for pinoresinol applied orally at a concentration of 100 mg/mL. Moreover, podophyllotoxin and burchellin reduced the excretion of the insect in 24 h while the other evaluated lignans did not have any effect on the excretion.

Burchellin, a lignan isolated from the stems of Ocotea cymbarum (Lauraceae) was very effective against Ae. aegypti and showed larval mortality of 100% at a concentration of 30 µg/mL, between 24 and 78 h after the treatment [16].

Overall, desoxypodophyllotoxin demonstrated 100% larval mortality on Ae. albopictus at all the concentrations evaluated until 7 days after treated. These results corroborate with our previous work, where this compound has shown a 100% larval mortality for Ae. aegypti at the same concentrations [10]. In addition, desoxypodophyllotoxin did not demonstrated toxicity toward the peritoneal macrophage cells of BALB/c mice, and thus, is worthy of further studies [10].

CONCLUSION

This study showed the larvicidal activity of the lignan desoxypodophyllotoxin (1) against the larvae of Ae. albopictus, and to some extent, confirms its potential as an application in the control of mosquitoes, the main vectors of arboviruses.

Table 1: Duration of development (A), viability (B) and mortality (C) among Aedes albopictus larvae (L3) treated with desoxypodophyllotoxin (1).

Treatment    L3-L4 (days)     Pupae (days) L3-adult (days)
   A X ± SD   VI X ± SD   VI X ± SD  VI
Control 2.1 ± 1.5a 1-10 11.2 ± 3a 5-18 18.8 ± 3a 7-20
Testimony 3.3 ± 2.1bc 1-10 11 ± 2.3a 5-17 13.6 ± 2.2a 8-18
1 µg/mL 2.8 ± 0.4ac 2-3   0   0   0   0
10 µg/mL 2.1 ± 0.6ad* 1-4   0   0   0   0
30 µg/mL 3.8 ± 1bc 2-5   0   0   0   0
     L3         L3-L4 L4-Pupae      L3-adult
   B X ± SD X ± SD  % X ± SD % X ± SD  %
Control 25 ± 0a 25 ± 0a 100 25 ± 0 100 25 ± 0 100
Testimony 25 ± 0a 25 ± 0a 100 25 ± 0a 100 25 ± 0 100
1 µg/mL 25 ± 0a 13 ± 8.7a 52   0  0   0   0
10 µg/mL 25 ± 0a 6 ± 6b* 25   0  0   0   0
30 µg/mL 25 ± 0a 7 ± 7b* 28   0  0   0   0
                  Larvae (L3+L4)            Pupae
   C  X ± SD   VI   %    X ± SD      VI   %
Control   0a   0   0      0      0    0
Testimony   0a   0   0      0      0    0
1 µg/mL 25± 0b*** 1-7 100      0      0    0
10 µg/mL 25± 0b*** 2-7 100      0      0    0
30 µg/mL 25± 0b*** 1-6 100      0      0    0
Experiments with 25 larvae (L3) of Ae. albopictus, for each test group and control, in triplicate, with three repetitions (n = 75). Mean and standard deviation (X ± SD). Range of variation (VI). Values followed by the same letter (a = a, b = b, c = c) have no significant differences. Significance levels according to the Tukey test, represented as ***P < 0.001, *P <0.1 vs. acetone: dimethyl sulfoxide (DMSO) (1:1) (testimony).

 

ACKNOWLEDGEMENTS

The authors thanks FUSVE/USS; Fundação de Amparo a Novas estratégias para o controle do mosquito Aedes aegypti, vetor da Dengue, Chikungunya e do virus Zika: uma abordagem integrada/RedeZIKA#1” and FIOCRUZ/CAPES-Brasil Sem Miséria. In addition, CGS is grateful to Dr Patrick H Huddleston (Nottingham Trent University, UK) for discussing the results of the isolation and idenfication of lignans from Podophyllum species.

REFERENCES

1. Cdc.gov [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention. [updated 2016 April 5; cited 2016 Dec 6].

2. Bonilauri P, Bellini R, Calzolari M, Angelini R, Venturi L, Fallacara F, et al. Chikungunya virus in Aedes albopictus, Italy. Emerg Infect Dis. 2008; 14: 852-854.

3. Schwartz LM, Halloran ME, Durbin AP, Longini Jr IM. The dengue vaccine pipeline: implications for the future of dengue control. Vaccine. 2015; 33: 3293-3298.

4. Mann RS, Kaufman PE. Natural product pesticides: their development, delivery and use against insect vectors. Mini Rev Org Chem. 2012; 9: 185-202.

5. MacRae WD, Towers GHN. Biological activities of lignans. Phytochemistry. 1984; 23: 1207-1220.

6. Saguez J, Attoumbré J, Giordanengo P, Baltora-Rosset S. Biological activities of lignans and neolignans on the aphid Myzus persicae (Sulzer). Arthropod Plant Interact. 2013; 7: 225-233.

7. Jackson DE, Dewick PM. Tumour-inhibitory aryltetralinlignans from Podophylum pleianthum. Phytochemistry. 1985; 24: 2407-2409.

8. Silva CG, Almeida VL, Campana PRV, Rocha MP. Plant Cell Cultures as Producers of Secondary Metabolites: Podophyllum Lignans as a Model. In: Jha S (ed.), Transgenesis and Secondary Metabolism, Reference Series in Phytochemistry (Mérillon JM, Ramawat KG, series eds.). Springer. 2016; 1-36.

9. Cabral MMO, Azambuja P, Gottlieb OR, Garcia ES. Effects of some lignans and neolignans on the development and excretion of Rhodnius prolixus. Fitoterapia. 2000; 71: 1-9.

10. Maleck M, de Oliveira Hollanda P, Serdeiro MT, de Araújo Soares RO, Honório NA, Silva CG. Toxicity and larvicidal activity of Podophyllum-based lignans against Aedes aegypti (Diptera: Culicidae). J Med Entomol. 2017; 54: 159-166.

11. World Health Organization. Dept. of Communicable Disease Prevention, Control and Eradication. WHO Pesticide Evaluation Scheme Guidelines for laboratory and field testing of mosquito larvicides. 2002. 39.

12. Sokal RR, Rohf FJ. Princípios y Metodos Estatísticos em la Investigación Biológica. Madri, Espanã: H. Blume Ed. 1979; 223.

13. Motulsky HJ. Analyzing data with GraphPad Prism, GraphPad Software Inc, San Diego, CA. 2002.

14. Hamilton MA, Russo RV. Trimmed Spearman-Karber method for estimating median lethal concentrations in bioassays. Thurston Environ Sci Technol. 1978; 11: 714-719. 

15. Inamori Y, Tsujibo H, Oki S, Kodama Y, Ogawa K. Mechanism of action of deoxypodophyllotoxin (Anthricin). III. The mode of delayed insecticidal action of deoxypodophyllotoxin. Chem Pharm Bull. 1986; 34: 2247-2250.

16. Narciso JOA, Soares ROA, Mallet JRS, Guimarães AE, Chaves COM, Barbosa- Filho JM, et al. Burchellin: study of bioactivity against Aedes aegypti. Parasit Vectors. 2014; 7: 172.

Maleck M, da Silva Pedra Parreira W, Serdeiro MT, Tavares Vieira RR, Honório NA, et al. (2017) Larvicidal Activity of the Lignan desoxypodophyllotoxin Against Aedes albopictus. Ann Community Med Pract 3(2): 1022.

Received : 30 Mar 2017
Accepted : 19 Apr 2017
Published : 21 Apr 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X